CHA2DS2-VASc评分<4的患者出血风险大于获益,因为他们卒中/或系统性栓塞风险本身较低,口服抗凝剂治疗导致的大出血风险大于预防卒中/或系统性栓塞的获益。 参考文献: Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T...
CHADS-P2A2RC 评分则有 24.9% 患者属于高危(≥ 4 分)、48.1% 为中危(2～3 分)、27.0% 为低危(≤ 1 分)。 每100 人年的主要不良心血管事件,两种方案均被认为是高危的患者为 4.8;ESC 标准高危但 CHADS-P2A2RC 低中危的患者为 2.1;ESC 标准低中危而 CHADS-P2A2RC 评分为高危的患者为 3.8;两种标准...
结论 单纯依赖CHA2DS2-VASc评分系统评价NVAF患者形成左心房(耳)的血栓风险并不准确.高龄,左心房增大,LVEF减低是NVAF患者发生左心耳血栓的独立危险因素.%Objective To investigate the role of CHA2DS2-VASc score in assessing risk of left atrial thrombus in patients with nonvalvular atrial fibrillation(NVAF);...
While the benefit outweighs the risk in most patients, careful consideration of the risk-to-benefit ratio is necessary in those at relatively very low (CHA2DS2-VASc score of 0) and low risk (CHA2DS2-VASc score of 1). Recommendations for anticoagulant therapy in patients with nonvalvular AF...
The CHA2DS2-VASc score has been widely adopted as a risk stratification tool for strokes in patients with atrial fibrillation and to help in deciding when anticoagulation therapy for stroke prophylaxis may be beneficial. The score as a whole has been well validated and has been included in the...
While the CHA2DS2-VASc score is a valuable tool, it does have limitations: It does not account for the quality of anticoagulation control, which is important in assessing the effectiveness of treatment. It may not be equally applicable to all populations, as some factors included in the score...
In this study, we investigated whether the CHA2DS2-VASc score could be used to estimate the need for hospitalization in the intensive care unit (ICU), the length of stay in the ICU, and mortality in patients with COVID-19. Patients admitted to Merkezefendi State Hospital because of COVID...
After adjustment for potential confounders, CHA2DS2-VASc score was significantly associated with POAF (odds ratio [OR]: 1.295, 95% CI: 1.205-1.391). However, further analyses showed that this effect was restricted to patients with a CHA2DS2-VASc score of ≥2 (OR: 1.813, 95% CI: 1.220-...
其中,CHA2DS2-VASc评分对于心房颤动患者的血栓事件风险更加敏感。近年来CHA2DS2-VASc评分还被报道用来评估急性冠脉综合征(ACS)的死亡率。2016年发表在ESC HEART FAILURE杂志(ESC HeartFailure 2016;3 261-269)的一篇研究(The CHA2DS2-VASc score asa predictor of high mortality in hospitalized heart failure ...
[Abstract] Objective To explore the value of score for atrial fibrillation recurrence risk score (CHA2DS2-VASc) combined with left ventricular ejection fraction (LVEF) in predicting cognitive impairment in patients with chronic heart failure and permanent atrial fibrillation. Methods A retrospective ...